| IMMUTEP LTD ADRS II/10 |
| USA |
| Gesundheit |
| US45257L1089 / A2H8YL |
| YP1A (Frankfurt) / IMMP (NASDAQ) |
| FRA:YP1A, ETR:YP1A, YP1A:GR, NASDAQ:IMMP |
| - |
| https://www.immutep.com/ |
|
Immutep Limited Sponsored ADR represents shares of..
>Volltext.. |
| 332.89 Mio. EUR |
| 261.11 Mio. EUR |
| - |
| -38.07 Mio. EUR |
| -34.43 Mio. EUR |
| -0.02 EUR |
| 0.91 Mio. EUR |
| 37.78 Mio. EUR |
| -34.78 Mio. EUR |
| 10.16 |
| - |
| -41.87% |
| - |
| - |
| - |
| - |
| IMMUTEP ADR, IMMUTEP |
| 18.12.25 |
|
||||
|